The most important financial indicators for the company Embryom Capital Investment Srl - Unique Identification Number 29900760:
sales in 2023 was
682.823
euro, registering a net profit of
220.867
euro and having an average number of
9
employees.
Firma isi desfasoara activitatea in domeniul Fabricarea produselor lactate si a branzeturilor having the NACE code 1051.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 19.4%, from 573.497 euro in the year 2022, to 682.823 euro in 2023.
The Net Profit increased by 187.435 euro, from 33.533 euro in 2022, to 220.867 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Embryom Capital Investment Srl - CUI 29900760
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
0
83.218
139.420
138.926
135.369
176.491
169.922
234.020
251.279
236.411
Current Assets
985
31.128
19.754
19.058
28.507
49.473
58.424
69.129
102.721
300.044
Inventories
0
8.547
8.169
12.721
15.997
17.329
22.233
26.115
26.712
27.908
Receivables
72
12.749
10.323
6.083
10.285
14.254
16.053
19.381
29.126
21.967
Cash
913
9.831
1.261
254
2.225
17.890
20.137
23.632
46.883
250.169
Shareholders Funds
689
824
3.762
3.947
28.656
128.544
124.491
152.611
186.617
406.918
Social Capital
67
135
134
131
129
126
248
243
243
243
Debts
296
113.522
155.412
154.038
135.220
97.420
103.854
146.206
163.167
129.537
Income in Advance
0
0
0
0
0
0
0
4.332
4.215
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"1051 - 1051"
CAEN Financial Year
1051
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
300.044 euro in 2023 which includes Inventories of
27.908 euro, Receivables of
21.967 euro and cash availability of
250.169 euro.
The company's Equity was valued at
406.918 euro, while total Liabilities amounted to
129.537 euro.
Equity increased by 220.866 euro, from 186.617 euro in 2022, to 406.918 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Embryom Capital Investment Srl